The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech stocks saw muted sentiment in the holiday-shortened week ending July 5 after a strong rebound in the later part of the previous week. Activity was light, although news on clinical trial readouts continued to flow. read more.....»»

Here's a few must-watch biotech catalysts this week. Conferences Panamerican League of Associations for Rheumatology Congress – April 7-11 at Hotel Hilton, Buenos Aires, Argentina. read more.....»»

After a lackluster show mid-way through the week despite M&A news and earnings, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) staged a recovery in the later part of the week. As the sector struggle.....»»

After a lackluster show mid-way through the week despite M&A news and earnings, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) staged a recovery in the later part of the week. read more.....»»

Aft.....»»

After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions. read more.....»»

Below is a list of notable corporate events for the week beginning June 18. Note, this list is not comprehensive and all dates are subject to change. All times are ET. Monday Conferences Blockchain Economic Forum June 16-19 FDA/Biotech Latest Rat.....»»

Biotech stocks held their ground in a holiday-shortened week amid a drought of market-moving catalysts. Looking ahead, the following are catalytic events for biotech investors to watch.  read more.....»»

Biotech stocks continued to see lackluster sentiment this week. The upcoming week's catalytic events could have a major say in charting the course for biotech stocks. Stay tuned to the following events. Conferences.....»»

Biotech stocks continued to see lackluster sentiment this week. The upcoming week's catalytic events could have a major say in charting the course for biotech stocks. Stay tuned to the following events. read more.....»»

Despite Friday's recovery, biotech stocks continued to hemorrhage last week following declines two weeks of declines. read more.....»»

Despite Friday's recovery.....»»

Notwithstanding the scanty news flow, biotech stocks came under intense s.....»»

Notwithstanding the s.....»»

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»

Large-cap pharma stocks are seeing some upward momentum and are on track to f.....»»

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYS.....»»

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYSE: NVS) and Illumina, Inc. read more.....»»

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came under pressure following the U.S. read more.....»»

Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. read more.....»»